IL114571A - Substituted benzamidines, pharmaceutical compositions containing them, their preparation and use - Google Patents

Substituted benzamidines, pharmaceutical compositions containing them, their preparation and use

Info

Publication number
IL114571A
IL114571A IL11457195A IL11457195A IL114571A IL 114571 A IL114571 A IL 114571A IL 11457195 A IL11457195 A IL 11457195A IL 11457195 A IL11457195 A IL 11457195A IL 114571 A IL114571 A IL 114571A
Authority
IL
Israel
Prior art keywords
methyl
imino
amine
pct
phenoxymethyl
Prior art date
Application number
IL11457195A
Other languages
English (en)
Other versions
IL114571A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL114571A0 publication Critical patent/IL114571A0/xx
Publication of IL114571A publication Critical patent/IL114571A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL11457195A 1994-07-13 1995-07-12 Substituted benzamidines, pharmaceutical compositions containing them, their preparation and use IL114571A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424713A DE4424713A1 (de) 1994-07-13 1994-07-13 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe

Publications (2)

Publication Number Publication Date
IL114571A0 IL114571A0 (en) 1995-11-27
IL114571A true IL114571A (en) 2003-09-17

Family

ID=6523047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11457195A IL114571A (en) 1994-07-13 1995-07-12 Substituted benzamidines, pharmaceutical compositions containing them, their preparation and use

Country Status (36)

Country Link
US (1) US5731332A (pl)
EP (1) EP0770059B1 (pl)
JP (1) JP2931410B2 (pl)
KR (1) KR100421580B1 (pl)
CN (1) CN1083830C (pl)
AT (1) ATE178590T1 (pl)
AU (1) AU700585B2 (pl)
BG (1) BG62090B1 (pl)
BR (1) BR9508374A (pl)
CA (1) CA2194885C (pl)
CO (1) CO4410184A1 (pl)
CZ (1) CZ289376B6 (pl)
DE (2) DE4424713A1 (pl)
DK (1) DK0770059T3 (pl)
EE (1) EE03311B1 (pl)
ES (1) ES2131830T3 (pl)
FI (1) FI970094L (pl)
GR (1) GR3030043T3 (pl)
HR (1) HRP950365B1 (pl)
HU (1) HU224823B1 (pl)
IL (1) IL114571A (pl)
MX (1) MX9700273A (pl)
MY (1) MY117090A (pl)
NO (1) NO307373B1 (pl)
NZ (1) NZ287883A (pl)
PE (1) PE32496A1 (pl)
PL (1) PL179595B1 (pl)
RO (1) RO118653B1 (pl)
RU (1) RU2159228C2 (pl)
SA (1) SA95160355B1 (pl)
SK (1) SK281744B6 (pl)
TW (1) TW555738B (pl)
UA (1) UA45351C2 (pl)
WO (1) WO1996002497A1 (pl)
YU (1) YU48934B (pl)
ZA (1) ZA955780B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
DK0813525T3 (da) * 1995-03-10 2004-02-16 Berlex Lab Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
WO1996036347A1 (en) * 1995-05-17 1996-11-21 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19636689A1 (de) 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) * 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW513402B (en) * 1997-05-30 2002-12-11 Daiichi Seiyaku Co Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives
US6046224A (en) * 1997-10-15 2000-04-04 City Of Hope 12 (S)--hete receptor blockers
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE10000907A1 (de) * 2000-01-12 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aryl-iminomethyl-carbaminsäureestern
US6417382B2 (en) 2000-01-12 2002-07-09 Boehringer Ingelheim Pharma Kg Process for preparing aryl-iminomethyl-carbamino acid esters
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
WO2002055065A2 (en) * 2001-01-16 2002-07-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
RU2004102399A (ru) * 2001-07-14 2005-05-27 Берингер Ингельхайм Фарма Гмбх Ко.Кг (De) Лекарственная композиция, содержащая ltb4-антагонист
WO2003017994A1 (en) * 2001-08-31 2003-03-06 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
RS20050390A (sr) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Farmaceutska kompozicija koja obuhvata ltb4 antagonist i koks-2 inhibitor ili kombinovani koks1/2 inhibitor
DE10350528A1 (de) * 2003-10-29 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
WO2006057501A1 (en) * 2004-11-23 2006-06-01 Dong Wha Pharmaceutical. Ind. Co., Ltd. N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methansulfonic acid salt
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
US12275687B2 (en) 2017-05-12 2025-04-15 Riken Class A GPCR-binding compound modifier

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550192B1 (fr) * 1983-08-03 1986-04-04 Sanofi Sa Nouveaux derives de la benzamidine a activite antimicrobienne, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
ATE125791T1 (de) * 1991-06-11 1995-08-15 Ciba Geigy Ag Amidino-verbindungen, ihre herstellung und verwendung als arzneimittel.
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
DK0902013T3 (da) * 1992-02-05 2002-03-25 Boehringer Ingelheim Pharma Hidtil ukendte amidinderivater, deres fremstilling og anvendelse som lægemidler med LTB4-antagonistisk virkning
US5455274A (en) * 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives

Also Published As

Publication number Publication date
CO4410184A1 (es) 1997-01-09
SK281744B6 (sk) 2001-07-10
EP0770059B1 (de) 1999-04-07
DE59505600D1 (de) 1999-05-12
CN1083830C (zh) 2002-05-01
NO307373B1 (no) 2000-03-27
TW555738B (en) 2003-10-01
CA2194885C (en) 2006-04-25
JP2931410B2 (ja) 1999-08-09
HK1011966A1 (en) 1999-07-23
SK1997A3 (en) 1997-08-06
HUT77220A (hu) 1998-03-02
DE4424713A1 (de) 1996-01-18
CZ289376B6 (cs) 2002-01-16
BG101105A (bg) 1998-04-30
NZ287883A (en) 1999-02-25
EE03311B1 (et) 2000-12-15
PE32496A1 (es) 1996-08-12
DK0770059T3 (da) 1999-10-18
PL318115A1 (en) 1997-05-12
EP0770059A1 (de) 1997-05-02
NO970122L (no) 1997-01-10
UA45351C2 (uk) 2002-04-15
US5731332A (en) 1998-03-24
HU224823B1 (en) 2006-02-28
FI970094A7 (fi) 1997-01-10
MY117090A (en) 2004-05-31
RU2159228C2 (ru) 2000-11-20
BG62090B1 (bg) 1999-02-26
CN1152304A (zh) 1997-06-18
YU48934B (sh) 2002-12-10
IL114571A0 (en) 1995-11-27
AU700585B2 (en) 1999-01-07
KR970704675A (ko) 1997-09-06
GR3030043T3 (en) 1999-07-30
FI970094A0 (fi) 1997-01-10
WO1996002497A1 (de) 1996-02-01
FI970094L (fi) 1997-01-10
MX9700273A (es) 1997-05-31
ZA955780B (en) 1996-01-15
KR100421580B1 (ko) 2004-07-31
ES2131830T3 (es) 1999-08-01
HRP950365B1 (en) 2000-04-30
RO118653B1 (ro) 2003-08-29
PL179595B1 (pl) 2000-09-29
AU2674295A (en) 1996-02-16
HU9700059D0 (en) 1997-02-28
BR9508374A (pt) 1998-05-26
SA95160355B1 (ar) 2005-06-13
CA2194885A1 (en) 1996-02-01
CZ6697A3 (cs) 1998-02-18
HRP950365A2 (en) 1997-08-31
NO970122D0 (no) 1997-01-10
ATE178590T1 (de) 1999-04-15
YU45295A (sh) 1997-12-05
JPH10502645A (ja) 1998-03-10

Similar Documents

Publication Publication Date Title
IL114571A (en) Substituted benzamidines, pharmaceutical compositions containing them, their preparation and use
NO308076B1 (no) Azadioksacykloalkener, fungicidmiddel inneholdende disse, anvendelse for fremstilling av fungicide midler, samt mellomprodukter
CY2176B1 (en) Watersoluble azole antifungals
ATE185555T1 (de) Monoamin oxydase b hemmende verbidungen verfahren zu ihrer herstellung un ihrer verwendung
DE69231445D1 (de) Triazole enthaltende antifungizide mittel
GB9405492D0 (en) Chemical compounds
TW261614B (pl)
ZA956476B (en) N-substituted azobiccloheptane derivatives, the preparation and use thereof.
DE69523581D1 (de) Anti-helicobacter ester- oder carbamatderivate von azolonen
DE59604901D1 (de) Carbamoylcarbonsäureamide
GR3025116T3 (en) Process for the preparation of n-carbonylarylimines useful for the synthesis of therapeutically active taxoids
DE59010091D1 (de) Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees